Sandbox chemo1: Difference between revisions
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
== Chemotherapeutic Agents by Category == | == Chemotherapeutic Agents by Category == | ||
=== Cytotoxic Chemotherapy === | |||
==== Alkylating agents ==== | ==== Alkylating agents ==== | ||
Revision as of 20:25, 20 February 2015
Chemotherapeutic Agents by Category
Cytotoxic Chemotherapy
Alkylating agents
Nitrogen mustards
- Chlorambucil (Leukeran)
- Cyclophosphamide (Cytoxan)
- Ifosfamide (Iflex)
- Melphalan (Alkeran)
- Mechlorethamine (Mustargen)
Ethylenimines
Methylhydrazine derivative
Alkyl sulfonate
Nitrosoureas
Triazenes
Platinum coordination complexes
Anthracyclines
Antimetabolites
- Capecitabine (Xeloda)
- Fluorouracil (Adrucil, Efudex)
- Floxuridine (FUDR)
- Fludarabine (Fludara)
- Gemcitabine (Gemzar)
- Hydroxyurea (Hydrea)
- Mercaptopurine (Purinethol)
- Methotrexate (Mexate,Folex)
Antimitotic agent
- Docetaxel (Taxotere)
- Eribulin (Halaven)
- Etoposide (Vespid)
- Ixabepilone (Ixempra)
- Vinblastine (Velban,Velsar)
- Vincristine (Oncovin,Vincasar)
- Vinorelbine (Navelbine)
DNA synthesis inhibitors
Microtubule inhibitors
Nitrogen mustards
Nitrosureas
Platinum agents
Proteasome inhibitors
Taxanes
Topoisomerase inhibitors
Vinca alkaloids
Endocrine therapy
Antiandrogens
- Abiraterone (Zytiga)
- Bicalutamide (Casodex)
- Dutasteride (Avodart)
- Enzalutamide (Xtandi)
- Finasteride (Proscar)
- Flutamide (Eulexin)
- Ketoconazole (Nizoral)
- Leuprolide (Lupron)
- Nilutamide (Nilandron)
- Triptorelin (Trelstar)
Steroid synthesis inhibitors
- Abiraterone (Zytiga)
- Aminoglutethimide (Cytadren)
- Anastrozole (Arimidex)
- Exemestane (Aromasin)
- Letrozole (Femara)
- Mitotane (Lysodren)
Androgen receptor inhibitors
5α-reductase inhibitors
GnRH agonists
GnRH antagonists
Aromatase inhibitors
Selective estrogen receptor modulators
Biologics
Antibody medications
- Cetuximab (Erbitux)
- Denosumab (Xgeva)
- Ibritumomab tiuxetan (Zevalin)
- Ipilimumab (Yervoy)
- Nivolumab (Opdivo)
- Obinutuzumab (Gazyva)
- Ofatumumab (Arzerra)
- Pembrolizumab (KEYTRUDA)
Antibody-drug conjugates
Anti-HER2 medications
Enzymes
IL-6 inhibitors
IL-2 inhibitors
Immunotherapy
Immunomodulatory drugs (IMiDs)
Hematopoietic Growth Factors
Erythrocyte growth factors
Granulocyte growth factors
Megakaryocyte growth factors
Supportive Medications
Chemotherapy protective agents
- Amifostine (Ethyol)
- Cyanocobalamin
- Dexrazoxane (Zinecard)
- Folinic acid (Leucovorin)
- Glucarpidase (Voraxaze)
- Levoleucovorin (Fusilev)
- Mesna (Mesnex)
Antiemetic agents
RANK ligand inhibitors
Miscellaneous
Antibiotic
Bisphosphonate
Endocrine-Metabolic agents
HDAC inhibitors
Hedgehog pathway inhibitors
Kinase inhibitors
- Afatinib (Gliotrif)
- Cabozantinib (Cometriq)
- Crizotinib (Xalkori)
- Dasatinib (Sprycel)
- Erlotinib (Tarceva)
- Ibrutinib (Imbruvica)
- Idelalisib (Zydelig)
- Lapatinib (Tykerb)
- Nilotinib (Tasigna)
- Palbociclib (Ibrance)